Literature DB >> 32970097

A Critical Review of Multimodal Interventions for Cachexia.

Clare McKeaveney1, Peter Maxwell2,3, Helen Noble1, Joanne Reid1.   

Abstract

Currently, there are no standardized treatments for cachexia or severe wasting. There is a growing consensus advocating multimodal interventions to address the complex pathogenesis and metabolic alterations in these conditions. This review examined multimodal treatments intended to alleviate and/or stabilize cachexia and severe wasting. The objectives of this review were to 1) identify multimodal interventions for the treatment of cachexia or associated wasting syndromes in patients with a chronic illness, 2) assess the quality of these studies, and 3) assess the effectiveness of multimodal interventions. Electronic databases including PubMed, MEDLINE, EMBASE, Scopus, Web of Science, Cochrane Library, CINAHL, PEDro, OpenGrey, and clinicaltrials.org were systematically searched using both text words and MeSH (medical subject heading) terms. The literature revealed a dearth of large, well-conducted trials in this area. Fourteen trials (n = 5 cancer, n = 5 chronic obstructive pulmonary disease, n = 4 chronic kidney disease) were included in this review. A total of 1026 patients were included across all studies; sample size ranged between 21 and 138 patients. Baseline and follow-up data were collected between 6 wk and 24 mo. All demonstrated some improvement in favor of the treatment groups, in relevant measures of body composition, nutrition, biomarkers, and functionality; however, caution should be applied due to the heterogenous nature of the interventions and small sample sizes. Overall, the evidence from this review supports the role of multimodal interventions in the treatment of severe wasting. However, randomized controlled trials with a powered sample size and sufficiently lengthy interaction period are necessary to assess if multimodal interventions are effective forms of therapy for improving body composition and nutritional and physical status in patients with cachexia and wasting. The protocol for this review is registered with Prospero (ID: CRD42019124374).
© The Author(s) 2020. Published by Oxford University Press on behalf of the American Society for Nutrition.

Entities:  

Keywords:  cachexia; interventions; multimodal; review; wasting

Mesh:

Year:  2021        PMID: 32970097     DOI: 10.1093/advances/nmaa111

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   8.701


  7 in total

1.  The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.

Authors:  Hidetaka Wakabayashi; Hidenori Arai; Akio Inui
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-12-31       Impact factor: 12.910

Review 2.  Leucine Supplementation in Cancer Cachexia: Mechanisms and a Review of the Pre-Clinical Literature.

Authors:  Anna G Beaudry; Michelle L Law
Journal:  Nutrients       Date:  2022-07-09       Impact factor: 6.706

Review 3.  [Research Progress of Pharmacological Therapy and Nutritional Support for Cachexia 
in Lung Cancer Patients].

Authors:  Jiemin Wang; Weihui Jia; Danyang Li; Yanmei Song; Ningxin Sun; Ke Yang; Hongli Li; Chonggao Yin
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-06-20

Review 4.  Targeting cancer cachexia: Molecular mechanisms and clinical study.

Authors:  Yong-Fei Wang; Zi-Yi An; Dong-Hai Lin; Wei-Lin Jin
Journal:  MedComm (2020)       Date:  2022-09-10

Review 5.  Barriers in Nursing Practice in Cancer Cachexia: A Scoping Review.

Authors:  Rika Sato; Tateaki Naito; Naoko Hayashi
Journal:  Asia Pac J Oncol Nurs       Date:  2021-08-27

Review 6.  The Role of Nurse in the Multidisciplinary Management of Cancer Cachexia.

Authors:  Yiyuan Zhao; Dong Pang; Yuhan Lu
Journal:  Asia Pac J Oncol Nurs       Date:  2021-08-27

Review 7.  Revisiting Cancer Cachexia: Pathogenesis, Diagnosis, and Current Treatment Approaches.

Authors:  Mudasir Rashid Baba; Sajad Ahmad Buch
Journal:  Asia Pac J Oncol Nurs       Date:  2021-08-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.